AR022113A1 - Eritropoyetina en el tratamiento de la anemia en animales domesticos y ganado - Google Patents

Eritropoyetina en el tratamiento de la anemia en animales domesticos y ganado

Info

Publication number
AR022113A1
AR022113A1 ARP990106237A ARP990106237A AR022113A1 AR 022113 A1 AR022113 A1 AR 022113A1 AR P990106237 A ARP990106237 A AR P990106237A AR P990106237 A ARP990106237 A AR P990106237A AR 022113 A1 AR022113 A1 AR 022113A1
Authority
AR
Argentina
Prior art keywords
livestock
domestic animals
anemia
erythropoyetin
treatment
Prior art date
Application number
ARP990106237A
Other languages
English (en)
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of AR022113A1 publication Critical patent/AR022113A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1816—Erythropoietin [EPO]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Fodder In General (AREA)

Abstract

La presente se dirige a un procedimiento de tratamiento de anemia en animales domésticos y ganado (particularmente gatos, perros y cerdos) mediante laadministracion de vectores de expresion que codifican la eritropoyetina canina, felina o porcina. Además, la presente comprende composiciones farmacéuticas quecontienen los vectores de expresion.
ARP990106237A 1998-12-17 1999-12-07 Eritropoyetina en el tratamiento de la anemia en animales domesticos y ganado AR022113A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US11265198P 1998-12-17 1998-12-17

Publications (1)

Publication Number Publication Date
AR022113A1 true AR022113A1 (es) 2002-09-04

Family

ID=22345129

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP990106237A AR022113A1 (es) 1998-12-17 1999-12-07 Eritropoyetina en el tratamiento de la anemia en animales domesticos y ganado

Country Status (9)

Country Link
EP (1) EP1013288A3 (es)
JP (1) JP2000178207A (es)
CN (1) CN1230196C (es)
AR (1) AR022113A1 (es)
AU (1) AU772503B2 (es)
CA (1) CA2288341C (es)
HK (1) HK1029532A1 (es)
NZ (1) NZ501193A (es)
ZA (1) ZA997266B (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2326384A1 (en) 1998-04-22 1999-10-28 Cornell Research Foundation, Inc. Canine erythropoietin gene and recombinant protein
US6696411B1 (en) 1998-04-22 2004-02-24 Cornell Research Foundation, Inc. Canine erythropoietin gene and recombinant protein
CN1675242A (zh) * 2002-08-09 2005-09-28 默克专利有限公司 ***中的t－细胞表位
WO2007026772A1 (ja) * 2005-08-31 2007-03-08 Kaneka Corporation ネコ由来タンパク質のコード配列を含む外来性遺伝子を含むトランスジェニック鳥類およびその作製法
BR112012008341A2 (pt) * 2009-09-15 2020-08-25 Kaneka Corporation eritropoietina modificada à qual molécula de cadeia longa solúvel em água é adicionada
RU2535012C1 (ru) * 2013-12-11 2014-12-10 Илья Николаевич Медведев Способ нормализации тромбоцитарной активности у новорожденных телят с железодефицитной анемией
RU2593336C1 (ru) * 2015-08-28 2016-08-10 Илья Николаевич Медведев Способ нормализации липидного состава тромбоцитарных мембран у новорожденных телят с анемией
RU2593337C1 (ru) * 2015-08-31 2016-08-10 Илья Николаевич Медведев Способ нормализации липидного состава мембран нейтрофилов у новорожденных телят с железодефицитной анемией
KR20180057636A (ko) * 2015-08-31 2018-05-30 더 트러스티스 오브 더 유니버시티 오브 펜실바니아 반려 동물 치료용 aav-epo
RU2593338C1 (ru) * 2015-08-31 2016-08-10 Илья Николаевич Медведев Способ нормализации липидного состава эритроцитарных мембран у новорожденных телят с железодефицитной анемией
RU2675365C1 (ru) * 2017-12-22 2018-12-19 Илья Николаевич Медведев Способ нормализации активности супероксиддисмутазы нейтрофилов у новорожденных телят с дефицитом железа
RU2675255C1 (ru) * 2017-12-22 2018-12-18 Илья Николаевич Медведев Способ нормализации активности супероксиддисмутазы эритроцитов у новорожденных телят с дефицитом железа

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2134773A1 (en) * 1992-06-04 1993-12-09 Robert J. Debs Methods and compositions for in vivo gene therapy
US5846528A (en) * 1996-01-18 1998-12-08 Avigen, Inc. Treating anemia using recombinant adeno-associated virus virions comprising an EPO DNA sequence

Also Published As

Publication number Publication date
CA2288341C (en) 2005-01-04
ZA997266B (en) 2001-05-23
CN1265921A (zh) 2000-09-13
AU772503B2 (en) 2004-04-29
CN1230196C (zh) 2005-12-07
EP1013288A2 (en) 2000-06-28
JP2000178207A (ja) 2000-06-27
AU5956099A (en) 2000-06-22
NZ501193A (en) 2001-06-29
CA2288341A1 (en) 2000-06-17
HK1029532A1 (en) 2001-04-06
EP1013288A3 (en) 2002-01-09

Similar Documents

Publication Publication Date Title
AR022113A1 (es) Eritropoyetina en el tratamiento de la anemia en animales domesticos y ganado
AR031949A1 (es) Un gel acuoso adecuado para la ingestion por un gato o un perro, la dieta que lo contiene y metodo de administracion de dicho gel
AR045142A1 (es) Composicion veterinaria masticable ductil de buen sabor
DE69525545D1 (de) Wirkstoff zur erhöhung der produktion und der zucht von tieren in der geflügelindustrie
BRPI0412332A (pt) método para aumentar nìveis de antioxidante no sangue em um felino, e, composição para dieta adequada para alimentar animais de companhia jovens
PT1391155E (pt) Composicao para utilizacao em nutricao animal compreendendo uma matriz de libertacao controlada processo para prepara-la e sua utilizacao
SE9901733D0 (sv) A composition containing carvacrol and thymol for use as a bactericide
AU7285487A (en) Anthelmintic quaternaryalkyl acylhydrazones, method of use and compositions
FR2785807B1 (fr) Formulation de complement alimentaire, composition alimentaire la comprenant, ses utilisations
AR040488A1 (es) Preparaciones que contienen al menos un diformiato
DK0616494T3 (da) 1-[N-(halo-3-pyridylmethyl)]-N-methylamino-1-alkylamino-2-nitroethylenderivater til bekæmpelse af lopper på husdyr
BR0015060A (pt) Agentes para promover engorda de animais e método para promover engorda
KR920003856A (ko) 벼룩을 구제하는 방법 및 구제용 제제
EA200000305A1 (ru) 8а-АЗАЛИДЫ КАК АНТИМИКРОБНЫЕ АГЕНТЫ В ВЕТЕРИНАРИИ
BR9905749A (pt) Eritropoietina no tratamento de anemia em animais domésticos e animais de criação
KR860004587A (ko) 동물 성장 자극제 조성물 및 그 제조 방법
DK1128737T3 (da) Anvendelse af vækstfremmende kraftfoder til dyr
DE69217227D1 (de) Verwendung von dioxapyrrolomycin als antiparasitisches mittel und dafür verwendbare zusammensetzung
SE9000046D0 (sv) Medel foer att foerbaettra miljoe och haelsotillstaand foer djur och skoetare t ex i svingaardar och haeststallar
ATE22389T1 (de) Verfahren zur anwendung ergotroper wirkstoffkombinationen in der aufzucht und mast von nutztieren.
DE60229502D1 (de) Verfahren und mittel zur behandlung von krebs bei hunden
DU PRESIDENT SCIENTIFIC* RUBRIQUE SCIENTIFIQUE
RU95112999A (ru) Способ профилактики некробактериоза животных
KR20030080457A (ko) 애완견 사료 장기보존 제조 공법
TH66837A3 (th) อีริโธรพอยเอติน ในการรักษาโรคโลหิตจางของสัตว์เลี้ยงและปศุสัตว์

Legal Events

Date Code Title Description
FB Suspension of granting procedure